UVA scientists have developed K-9, an experimental drug that reversed MS damage in mice, restoring mobility and vision. Derived from HIV and hepatitis B drugs, K-9 targets MS-related brain and spinal cord damage. Human clinical trials are needed to confirm its effectiveness and safety.

Walmart's CEO John Furner confirms the company will not use AI or personal data for individual pricing, maintaining consistent prices across all customers. Digital price tags are being rolled out to improve efficiency, not to introduce dynamic pricing. The initiative aims to modernize pricing ...

A Kelvin wave is expected to hit California's coast around Oct. 1, potentially raising sea levels by up to a foot. Combined with a record-strength El Niño and the highest king tides in 18 years, scientists warn of severe coastal flooding and erosion risks for low-lying communities.

President Trump will host an AI summit at the White House on Tuesday, with tech leaders like Mark Zuckerberg. The meeting aims to balance innovation and regulation, amid fears of AI threats. The U.S. advocates minimal new regulations, focusing on novel situations.

PepsiCo plans to raise prices on snacks and drinks like Doritos and SunChips by year-end due to rising costs. Despite recent price cuts, new increases aim to offset inflation and higher expenses. PepsiCo's international growth remains strong, but North America faces challenges.

President Trump will unveil America.gov, an AI-powered portal to simplify federal service access, on Tuesday. The platform aims to centralize government resources, enhancing user experience. The launch event in Washington, D.C., will feature key dignitaries and industry leaders.

Medicare announces 2027 rate changes: Advantage premiums drop to $12, while Part D drug plans rise slightly to $36. Open enrollment runs October 15 to December 7. Beneficiaries should review coverage details, including premiums and drug lists, before choosing a plan for 2027.

President Trump denies an Axios report claiming the U.S. is considering sanctions relief for Iran in exchange for nuclear concessions. Trump insists he has offered Iran "NOTHING" and demands Axios retract the story. Talks between the U.S. and Iran are expected to continue amid diplomatic effor...